Elon Musk Switches to 'King Kong' Weight-Loss Drug After Ozempic Use [2FygMmFYLKp]

Elon Musk Switches to 'King Kong' Weight-Loss Drug After Ozempic Use [2FygMmFYLKp]

| 1h 28m 28s | Video has closed captioning.

Save money, buy cheap here: USA: or Europe DE: or Europe UK: We create a news channel fully dedicated to the fastest information from the world. Your news on every topic and without secrets. We deal with politics, but also science, entertainment and the world of Stars. If you are looking for information about politicians you have come to the right place. If you are looking for mysteries, secrets and curiosities about celebrities and politicians, it's good that you are here. The latest news and information, as well as news from around the world and Poland regarding technology, science and health. Are you looking for equipment reviews, opinions of other people? You will find out information about phones, tablets and others. Everything you need to know about Artificial Intelligence, i.e. AI, as well as Tesla and SpaxeX. Elon Musk appears to be experiencing weight loss after transitioning from Ozempic to a medication dubbed the "King Kong" of weight-loss drugs. The fifty-three-year-old entrepreneur admitted to using Mounjaro, a drug typically prescribed for type-two diabetes to regulate blood sugar levels, in a festive social media post on X. The Tesla CEO posted a picture of himself dressed as Santa Claus in front of a Christmas tree, captioning it "Ozempic Santa." He humorously added, "Like Cocaine Bear, but Santa and Ozempic! Technically, Mounjaro, but that doesn't have the same ring to it." Musk had previously used Ozempic, another diabetes medication popular among celebrities for weight loss, but sought an alternative due to the side effects, including what he described as “farting and burping like Barney from The Simpsons,” from high doses. He claims Mounjaro seems to have fewer side effects and is more effective, according to The Telegraph. Mounjaro was approved by the Food and Drug Administration (FDA) as a weight management drug in November two thousand and twenty-three under the brand name Zepbound. It earned the "King Kong" nickname due to its superior effectiveness compared to similar drugs, as noted by experts. However, doctors have issued warnings about misleading claims regarding the drug's safety, citing risks of severe injuries like stomach paralysis, gallbladder issues, and pancreatitis. Mounjaro, an injectable GLP-one inhibitor, works by suppressing food cravings and slowing stomach emptying, promoting weight loss. Studies show that patients using Mounjaro typically lose over twenty percent of their body weight, compared to less than fourteen percent with semaglutide, the key component in competing drugs like Wegovy and Ozempic. Research suggests that expanding public access to GLP-one drugs could save forty-two thousand lives annually in the U.S., including eleven thousand Type-two diabetes patients. Musk, chosen to lead President-elect Donald Trump's new Department of Government Efficiency, has openly advocated for weight-loss drugs, stating that making GLP inhibitors affordable would significantly improve health and lifespan for Americans. However, there is a division among Republicans on whether to continue President Biden's plan to expand insurance coverage for anti-obesity medications. Dr. Mehmet Oz, a proponent of weight-loss drugs who will head the Centers for Medicare and Medicaid Services, supports these medications. Conversely, Robert F. Kennedy Jr., nominated to lead the Department of Health and Human Services, is publicly against using drugs as the primary method to combat obesity, arguing that lifestyle changes should be the first step. Kennedy recently criticized the approximately nine million annual prescriptions in the U.S. for weight-loss drugs like Ozempic, citing the high costs of these medications and suggesting that redirecting those funds to provide healthy food would be a more effective solution. However, he slightly shifted his stance, acknowledging that GLP drugs "have a place" after Musk publicly endorsed them. Trump has also been the subject of Ozempic rumors. Joy Behar of "The View" suggested he was using the drug after co-host Sunny Hostin noted his slimmer appearance. Trump dismissed these claims and recently downplayed Musk's influence, asserting he would not be president because he was not born in the U.S. Musk, who has spent over a quarter of a billion dollars supporting Trump's presidential bid, is a frequent presence at Trump's Mar-a-Lago home. While Tirzepatide, the active ingredient in Mounjaro, has been praised as a transformative treatment, there are safety concerns regarding serious side effects. These include stomach paralysis and pancreatitis, the latter which can lead to life-threatening complications. While studies suggest a potential link between Mounjaro and increased risk of pancreatitis, more research is needed to identify who is more susceptible and why. #Entertainment #news #gossip #celebrity #science #tech #facts #keto acv cucumber #is keto gummies halal #lipozene diet pills review